Join our Telegram group and receive breaking and trending news updates directly on your phone.
Join for News Updates ✕
Foreign news with agency report.
(C) Realnews.
China has launched its first Artificial Intelligence-powered digital doctor platform dedicated to the management of Parkinson’s disease, a progressive neurological disorder increasingly affecting ageing populations worldwide.
The is a significant stride at the intersection of medicine and technology, according to medical experts.
Developed by Xuanwu Hospital of Capital Medical University, the platform represents a data-driven approach to modern healthcare delivery.
It is engineered to streamline patient support systems by minimizing repetitive consultations while enhancing access to accurate, evidence-based medical information.
The AI system is built on more than 20 years of clinical research, integrating vast datasets,including patient medical records, peer-reviewed academic studies, clinical reports, and educational resources.
It also incorporates global scientific literature, ensuring that its responses align with internationally validated standards in neurology and patient care.
According to Chen Biao, director of the hospital’s Parkinson’s disease clinical research and treatment centre, the digital doctor is capable of handling up to 90 per cent of routine patient inquiries.
This capability significantly reduces the cognitive and time burden on physicians, allowing them to focus on complex cases that demand specialized medical expertise.
Accessible via smartphones, the platform enables patients and caregivers to interact with the system in real time,asking questions about symptoms, disease progression, and management strategies.
The AI delivers scientifically grounded responses, helping to bridge knowledge gaps and improve patient awareness.
Importantly, the system is designed with ethical safeguards: it does not provide individualized treatment prescriptions.
Instead, it reinforces the role of human doctors in clinical decision-making, ensuring that diagnosis and treatment remain under professional medical supervision.
In addition to its advisory functions, the platform is integrated with the hospital’s digital infrastructure, allowing users to schedule appointments and access prescription services seamlessly,an innovation that reflects the broader trend toward telemedicine and smart healthcare ecosystems.
Experts believe such AI-driven tools could play a critical role in addressing the rising global burden of neurodegenerative diseases, particularly in countries with rapidly ageing populations.
By combining clinical science with machine intelligence, the initiative signals a future where healthcare is not only more efficient, but also more accessible and patient-centered.
Developers have indicated that future updates will further expand the platform’s capabilities, potentially incorporating advanced predictive analytics and personalized health monitoring,ushering in a new era of precision neurology.
With agency report.
